Clinical and Endoscopic Improvement of Inflammatory Bowel Disease with Curcumin Therapy: Experiences from Clinical Studies

Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, is a chronic inflammatory condition of the intestine one etiological factor for colon cancer development. Incidences still high around world, even with current therapy, emerging need innovational approach to increase achievement improvement remission. Curcumin natural compound derived from Curcuma longa has been well known its anti-inflammatory properties which possible be beneficial disease. This review aims provide clinical evidences effectively safety profile curcumin in treating both viewing future prospect an effective adjuvant therapy prevent relapse